28 Services ( View All )

WHAT IS JUVÉDERM® VOLUX® XC?

JUVÉDERM® VOLUX® XC is the first and only FDA-approved HA filler for improving lost definition in the jawline with lasting results. JUVÉDERM® VOLUX® XC can help achieve the look you want from all angles, with more definition in the jawline. Add volume to improve the shape and structure of the lower face and achieve a smooth, more defined look in the jawline with results that last up to 1 year.

What are the benefits of JUVÉDERM VOLUX XC?

JUVÉDERM® VOLUX™ XC offers a specialized solution for patients looking to achieve a more defined and sculpted jawline. Its durable formulation provides long-lasting results, making it an excellent choice for those seeking a nonsurgical approach to enhance their facial contours and achieve a more contoured jawline specifically.

Benefits of JUVÉDERM VOLUX XC include:

  • Enhanced jawline definition
  • Long-lasting results for up to a year or longer
  • Nonsurgical and minimally invasive
  • Improved facial balance and harmony
  • Quick treatment sessions with minimal downtime

JUVÉDERM VOLUX FAQ

What areas can be treated with JUVÉDERM VOLUX XC?

JUVÉDERM VOLUX XC is primarily used to treat the jawline and chin. It is ideal for addressing concerns related to a weak or undefined jawline, lack of chin projection, or the desire for a more sculpted lower face.

How long do the results of JUVÉDERM VOLUX XC last?

The results of JUVÉDERM VOLUX XC are long-lasting, with effects typically lasting up to 18 – 24 months. The duration may vary among individuals based on factors such as metabolism, lifestyle, and the amount of product injected.

How long does a JUVÉDERM VOLUX XC procedure take?

The duration of a JUVÉDERM VOUX XC procedure varies but is generally quick, often taking 30 minutes to an hour. The treatment involves a series of injections, and patients can resume normal activities shortly after the session.

Related Procedures

*Individual results are not guaranteed and may vary from person to person. Images may contain models.